Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02929108 · ClinicalTrials.gov registry record · NA
ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making)
A NA study of Cancer and Pain, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 489
- Enrollment target
- 3
- Study locations
NCT02929108: Completed NA study of Cancer and Pain, sponsored by Washington University School of Medicine.
NCT02929108 is a NA study of Cancer and Pain that has completed, run by Washington University School of Medicine. The registered enrollment target is 489 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02929108, a NA study of Cancer and Pain, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 489 participants
- Enrollment target
- 3
- Study locations
Study Summary
The project will test the effect of educating and supporting family caregivers of hospice cancer patients on their active participation in shared decision making in the plan of care for their patients.
Primary Outcome
A screening tool to quantify participant's anxiety. The scale ranges from 0-21. A higher score indicates a higher level of anxiety.
Interventions
- BEHAVIORAL Facebook
- BEHAVIORAL ACCESS
Study Locations (3)
Missouri
- Hospice Compassus - Columbia
- CrossRoads Hospice - Kansas City
- Barnes Jewish Hospice - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 489 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2021-11-22 |
| Phase | NA |
What the finished NCT02929108 record still lists
NCT02929108 is an interventional study that assigns participants to a tested intervention. The registered 489 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Facebook is the first listed.
NCT02929108 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02929108 about?
NCT02929108 is a clinical study titled "ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making)". The project will test the effect of educating and supporting family caregivers of hospice cancer patients on their active participation in shared decision making in the plan of care for their patients.
What is the current status of trial NCT02929108?
This trial is currently completed. It is a NA study. The enrollment target is 489 participants. The study started on 2017-04-01. Estimated completion is 2021-11-22.
What conditions does trial NCT02929108 study?
This clinical trial studies the following conditions: Cancer, Pain.
What interventions are being tested in trial NCT02929108?
The interventions under investigation include: Facebook (BEHAVIORAL), ACCESS (BEHAVIORAL).
Who is sponsoring clinical trial NCT02929108?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02929108 being conducted?
This trial has 3 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02929108's enrollment target sits among peer trials
489 134th of 615 higher than 482 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI